sglt2 inhibitors vs glp-1 3. Integration of GLP-1RA or SGLT2i in Patients With T2D With or at Risk of atherosclerotic CVD Study participants' HbA1c: effect of

Insurance coverage will be determined after FDA approval

Anti-nausea medications can also provide relief while individuals adjust to therapy and during dose increases

A pooled analysis of the STEP 1 through STEP 3 trials, published in Diabetes, Obesity and Metabolism in 2022, examined once-weekly semaglutide 2.4 mg in 2,117 participants against 1,262 on placebo

GLP-1, however, engages the GLP-1R/ERK1/2/HDAC6 axis to modulate downstream transcriptional activity, it lowers intracellular ROS, reduces Akt and ERK1/2 phosphorylation, restores HDAC6 expression, and thereby alleviates endothelial dysfunction and excessive autophagy (Zummo et al., 2017)

While Semaglutide GLP-1 injections have been shown to have impressive weight loss results, its important to note that these injections are not meant as a quick-fix solution

They also appear to decrease markers of systemic inflammation , which is critical because chronic inflammation fuels atherosclerosis (plaque buildup in arteries)